Literature DB >> 7772102

The yield of flexible fiberoptic sigmoidoscopy in the detection of asymptomatic colorectal neoplasia.

D C Wherry1, W M Thomas.   

Abstract

Recent evidence of a reduction in mortality rates from distal colorectal cancers in populations screened by rigid sigmoidoscopy suggests that further benefits may be achieved by the use of fiberoptic sigmoidoscopy as the screening modality. However, there is limited evidence as to the expected yield of neoplasia using the standard 60-cm instrument. The aim of this study was to determine the yield of neoplasia in an asymptomatic population in the at-risk age group undergoing fiberoptic sigmoidoscopy. Recruitment into the screening program was among State Department personnel. In total, 4,216 asymptomatic subjects (50-65 years) were offered flexible sigmoidoscopic screening performed following a simple enema bowel preparation. Those in whom a neoplastic condition was identified underwent further investigation (colonoscopy or barium enema). Of those offered screening 4,005 (95%) underwent the examination. Eleven carcinomas were detected at flexible sigmoidoscopy and two carcinomas were detected at further investigation in subjects with rectosigmoid polyps. The overall detection rate of carcinomas was 3.2 per 1,000 subjects screened. Histologically proven adenomas were detected in 217 subjects, 5.4% of the population screened. In this cohort of individuals flexible sigmoidoscopy appears to have been an acceptable form of screening. The detection rate of neoplasia, particularly colorectal adenomas, is higher than that reported from studies of fecal occult blood screening.

Entities:  

Mesh:

Year:  1994        PMID: 7772102     DOI: 10.1007/bf00642439

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  9 in total

1.  Value of periodic examinations in detecting cancer of the rectum and colon.

Authors:  R E HERTZ; M R DEDDISH; E DAY
Journal:  Postgrad Med       Date:  1960-03       Impact factor: 3.840

2.  Screening for colorectal neoplasia in asymptomatic patients using flexible fiberoptic sigmoidoscopy.

Authors:  D C Wherry
Journal:  Dis Colon Rectum       Date:  1981-10       Impact factor: 4.585

3.  Randomised, controlled trial of faecal occult blood screening for colorectal cancer. Results for first 107,349 subjects.

Authors:  J D Hardcastle; W M Thomas; J Chamberlain; G Pye; J Sheffield; P D James; T W Balfour; S S Amar; N C Armitage; S M Moss
Journal:  Lancet       Date:  1989-05-27       Impact factor: 79.321

4.  Screening sigmoidoscopy and colorectal cancer mortality.

Authors:  P A Newcomb; R G Norfleet; B E Storer; T S Surawicz; P M Marcus
Journal:  J Natl Cancer Inst       Date:  1992-10-21       Impact factor: 13.506

5.  Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests.

Authors:  D A Ahlquist; H S Wieand; C G Moertel; D B McGill; C L Loprinzi; M J O'Connell; J A Mailliard; J B Gerstner; K Pandya; R D Ellefson
Journal:  JAMA       Date:  1993-03-10       Impact factor: 56.272

6.  Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.

Authors:  W S Atkin; B C Morson; J Cuzick
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

7.  A case-control study of screening sigmoidoscopy and mortality from colorectal cancer.

Authors:  J V Selby; G D Friedman; C P Quesenberry; N S Weiss
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

8.  Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark.

Authors:  O Kronborg; C Fenger; J Olsen; K Bech; O Søndergaard
Journal:  Scand J Gastroenterol       Date:  1989-06       Impact factor: 2.423

9.  The prevention of invasive cancer of the rectum.

Authors:  V A Gilbertsen; J M Nelms
Journal:  Cancer       Date:  1978-03       Impact factor: 6.860

  9 in total
  1 in total

1.  Value of fentanyl in flexible sigmoidoscopy.

Authors:  Sanjoy Basu; Badri Krishnamurthy; Tim H Walsh
Journal:  World J Surg       Date:  2004-09       Impact factor: 3.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.